HALEY MEASE: Open Payments
NPI 1528637873 · BRANSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,839 in 109 payments from 21 companies in 2025. Trend: 2023 $1,024 · 2024 $1,026 · 2025 $1,839
Food & beverage: $1,839
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 18 | $300 |
| Amgen Inc. | 23 | $287 |
| Novo Nordisk Inc | 12 | $188 |
| Globus Medical, Inc. | 7 | $178 |
| Lilly USA, LLC | 10 | $165 |
| Novartis Pharmaceuticals Corporation | 6 | $99 |
| Ascendis Pharma Endocrinology Inc | 5 | $98 |
| Radius Health, Inc. | 4 | $83 |
| Corcept Therapeutics | 5 | $78 |
| SANOFI-AVENTIS U.S. LLC | 4 | $67 |
Products named: Dexcom G6 Transmitter, Senza, MOUNJARO, Ozempic, EVENITY, LEQVIO, Yorvipath, REPATHA.
Industry payments across MO — which companies pay providers there.
